BLERTA HAMZA: Open Payments
NPI 1053901702 · CLARKSBURG, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$332 in 13 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $103 · 2025 $332
Food & beverage: $332
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 4 | $103 |
| AstraZeneca Pharmaceuticals LP | 2 | $57 |
| Caris MPI, Inc. | 2 | $56 |
| Janssen Biotech, Inc. | 2 | $40 |
| Daiichi Sankyo Inc. | 1 | $27 |
| Stemline Therapeutics Inc. | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
Products named: KEYTRUDA, MI CANCER SEEK, IMFINZI, Enhertu, ERLEADA, Orserdu, SCEMBLIX, RYBREVANT.
Industry payments across MD — which companies pay providers there.
